Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of diabetes and hypertension in metabolic syndrome with renin-angiotensin system blockade
2007-000947-88Phase 4Terminated
- Sponsor
- Istituto Auxologico Italiano
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of losartan in hypertension (HTN) and type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Istituto Auxologico Italiano. Primary endpoints: Onset of diabetes and Onset of hypertension. Started Mar 2007; status: terminated.
02
Drugs
losartan
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-000947-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000947-88.